Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Therapeutic approaches to Alzheimer's disease.

Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J.

Brain. 2006 Nov;129(Pt 11):2840-55. Epub 2006 Oct 3. Review.

PMID:
17018549
2.

Alzheimer's and non-alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies.

Saddichha S, Pandey V.

Am J Alzheimers Dis Other Demen. 2008 Apr-May;23(2):150-61. doi: 10.1177/1533317507312957. Review.

PMID:
18332476
3.

Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway.

Masters CL, Beyreuther K.

Brain. 2006 Nov;129(Pt 11):2823-39. Epub 2006 Sep 29. Review.

PMID:
17012295
4.

Approaches to palliative therapies for Alzheimer's disease.

Robichaud AJ.

Curr Top Med Chem. 2006;6(6):553-68. Review.

PMID:
16712491
5.

[Therapy of Alzheimer's disease: current status and future development].

Schmidt R, Neff F, Lampl C, Benke T, Anditsch M, Bancher C, Dal-Bianco P, Reisecker F, Marksteiner J, Rainer M, Kapeller P, Dodel R.

Neuropsychiatr. 2008;22(3):153-71. Review. German.

PMID:
18826870
6.
7.

[Therapy of Alzheimer disease].

Kovács T.

Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Review. Hungarian.

8.

New concepts in the drug therapy of Alzheimer's disease.

Hake AM, Farlow MR.

Expert Opin Pharmacother. 2001 Dec;2(12):1975-83. Review.

PMID:
11825329
9.

[Fundamental data on the pathologies amyloid and Tau in Alzheimer's disease: which therapeutic perspectives?].

Checler F, Buée L.

Ann Pharm Fr. 2009 Mar;67(2):136-53. doi: 10.1016/j.pharma.2009.01.002. Epub 2009 Feb 28. Review. French.

PMID:
19298897
10.

Disease modifying approaches for Alzheimer's pathology.

Sadowski M, Wisniewski T.

Curr Pharm Des. 2007;13(19):1943-54. Review.

PMID:
17627527
11.

Therapeutic targets for Alzheimer's disease.

Tarditi A, Caricasole A, Terstappen G.

Expert Opin Ther Targets. 2009 May;13(5):551-67. doi: 10.1517/14728220902865614 . Review.

PMID:
19368497
12.

Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology.

Silvestrelli G, Lanari A, Parnetti L, Tomassoni D, Amenta F.

Mech Ageing Dev. 2006 Feb;127(2):148-57. Epub 2005 Nov 8. Review.

PMID:
16278007
13.

Therapeutic strategies for Alzheimer's disease.

Wolfe MS.

Nat Rev Drug Discov. 2002 Nov;1(11):859-66. Review.

PMID:
12415246
14.

Disease-modifying therapies in Alzheimer's disease: how far have we come?

Hüll M, Berger M, Heneka M.

Drugs. 2006;66(16):2075-93. Review.

PMID:
17112302
15.

Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.

Pákáski M, Kálmán J.

Neurochem Int. 2008 Nov;53(5):103-11. doi: 10.1016/j.neuint.2008.06.005. Epub 2008 Jun 17. Review.

PMID:
18602955
16.

Current drugs and future hopes in the treatment of Alzheimer's disease.

Windisch M, Hutter-Paier B, Schreiner E.

J Neural Transm Suppl. 2002;(62):149-64. Review.

PMID:
12456060
17.

Non-cholinergic pharmacotherapy approaches to the future treatment of Alzheimer's disease.

Castro A, Conde S, Rodriguez-Franco MI, Martinez A.

Mini Rev Med Chem. 2002 Feb;2(1):37-50. Review.

PMID:
12369956
18.

Alzheimer's disease and frontotemporal dementia: prospects of a tailored therapy?

Götz J, Ittner LM, Schonrock N.

Med J Aust. 2006 Oct 2;185(7):381-4. Review.

PMID:
17014407
19.

Future therapeutic approaches to Alzheimer's disease.

Davis KL.

J Clin Psychiatry. 1998;59 Suppl 11:14-6. Review.

20.

GSK-3 inhibitors for Alzheimer's disease.

Avila J, Hernández F.

Expert Rev Neurother. 2007 Nov;7(11):1527-33. Review.

PMID:
17997701

Supplemental Content

Support Center